Highvista Strategies LLC / ALXN
Highvista Strategies LLC’s Alexion Pharmaceuticals Inc Position
Does Highvista Strategies LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 21.5K shares worth $4M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q2 2021
Shares
21.5K
% of Portfolio
+2.80%
Quarters Held
2
position exited
Position History ALXN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of ALXN.